A common beta2-adrenoceptor gene haplotype protects against obesity in Swedish women.

[1]  E. Snyder,et al.  The Human Obesity Gene Map the Human Obesity Gene Map: the 2003 Update , 2022 .

[2]  P. Eriksson,et al.  Relationship between β-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women , 2004, International Journal of Obesity.

[3]  Kaisa Silander,et al.  The SLC6A14 gene shows evidence of association with obesity. , 2003, The Journal of clinical investigation.

[4]  S. Liggett,et al.  Pharmacology and physiology of human adrenergic receptor polymorphisms. , 2003, Annual review of pharmacology and toxicology.

[5]  R. Rosmond.  Association studies of genetic polymorphisms in central obesity: a critical review , 2003, International Journal of Obesity.

[6]  A. Palou,et al.  The glutamine 27 glutamic acid polymorphism of the β2‐adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population‐based study in Spain , 2003, Clinical endocrinology.

[7]  M. Skolnick,et al.  A major predisposition locus for severe obesity, at 4p15-p14. , 2002, American journal of human genetics.

[8]  D. Postma,et al.  β2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells , 2002, Thorax.

[9]  R S Judson,et al.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Large,et al.  The different effects of a Gln27Glu β2‐adrenoceptor gene polymorphism on obesity in males and in females , 1999, Journal of internal medicine.

[11]  I. Hall,et al.  Identification of novel polymorphisms within the promoter region of the human β2 adrenergic receptor gene , 1999, British journal of pharmacology.

[12]  S. Liggett,et al.  Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression. , 1998, The Journal of clinical investigation.

[13]  V. Large,et al.  Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. , 1998, Diabetes & metabolism.

[14]  R N Pierson,et al.  How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? , 1996, American journal of epidemiology.

[15]  I. Hall,et al.  Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. , 1995, American journal of respiratory cell and molecular biology.

[16]  S. Rössner,et al.  Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta2-adrenoceptors , 1994, Diabetologia.

[17]  S. Green,et al.  A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. , 1993, The Journal of biological chemistry.